首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷生技設備

市場調查報告書

商品編碼

1478061

全球自動化細胞成像系統市場規模、佔有率、成長分析，按產品、最終用戶、應用、技術、地區 - 產業預測，2024-2031

Global Automated Cell Imaging System Market Size, Share, Growth Analysis, By Product, By End users, By Application, By Technology, By Region - Industry Forecast 2024-2031

出版日期: 2024年05月01日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

自動化細胞成像系統的全球市場規模，2022年價值 1,089 億美元，預計將從2023年的1,183.7億美元成長到2031年的2,307.2億美元，預測期內（2024-2031年）年複合成長率為8.7%。

預計市場將以更快、更健康的速度擴張。因為世界上患有慢性病的人比以往任何時候都多。此外，加大新藥、疫苗研發投入也支持市場拓展。然而，由於高昂的維護成本和缺乏更換零件，自動細胞成像系統的市場並未如預期擴大。從全球來看，北美所佔比例最高。這得益於醫療產業較早採用最尖端科技。美國是這一領域的領先國家。由於醫療保健領域的大量投資，亞太地區迅速擴張。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東、非洲
- 海灣合作理事會國家
- 南非
- 其他中東、非洲地區

競爭格局

前5名企業比較
主要企業市場定位（2023年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Thermo Fisher Scientific Inc.
Carl Zeiss AG
Olympus Corporation
GE Healthcare
Leica Microsystems GmbH
PerkinElmer, Inc.
Nikon Corporation
Molecular Devices LLC
BD Biosciences
BioTek Instruments, Inc.
Sartorius AG
Agilent Technologies, Inc.
Tecan Group AG
Bruker Corporation
Merck KGaA
Yokogawa Electric Corporation
Hamilton Company
Danaher Corporation
Sysmex Corporation
Bio-Rad Laboratories, Inc.

簡介目錄

Product Code: SQMIG35J2035

Global Automated Cell Imaging System Market size was valued at USD 108.9 billion in 2022 and is poised to grow from USD 118.37 billion in 2023 to USD 230.72 billion by 2031, growing at a CAGR of 8.7% during the forecast period (2024-2031).

The market is anticipated to expand more quickly and at a healthier rate. It is because there are more chronic patients in the world than ever before. The expansion of the market is also being driven by increased investments in research and development of novel medications and vaccines. Nevertheless, the market for automated cell imaging systems is not expanding as quickly as it should due to high maintenance costs and a lack of replacement parts. Globally, North America has the largest proportion. The early adoption of cutting-edge technologies in the healthcare industry is to blame. The United States is the main nation in the area. Due to significant investment in the healthcare sector, the Asia-Pacific area is expanding at a quicker rate.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Automated Cell Imaging System Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the Market size includes the following details: The key players in the Market were identified through secondary research, and their Market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top Market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Automated Cell Imaging System Market Segmental Analysis

The global automated cell imaging system is categorized on the basis of product, end-user, technology, and region. With respect to segmentation by product, the market is grouped into time lapse, colocalization, and others. In terms of classification by end user, the market is segmented into hospitals, and research and diagnostic laboratories. On the basis of application, the market is segmented into live cell vivo imaging, and screening. Based on technology, the market is classified into fluorescence, luminescence, phase contrast, and others. Geographically, the market is segmented into Asia Pacific, Europe, North America, Middle East & Africa, and Latin America.

Drivers of the Global Automated Cell Imaging System Market

Our body exhibits certain genetic abnormalities as a result of radiation and lifestyle changes. This results in aberrant cell division, which causes tumors. Cancer is also brought on by specific chemicals that are exposed to food, water, and soil. In order to determine the dynamics and activities of telomeric repeat-containing RNA, automated cell imaging methods are also necessary for the development of novel cancer kinds. With the ability to examine digitized microscopic images of malignant cells, automated cell imaging is a novel and increasingly popular method for cellular research.

Restraints in the Global Automated Cell Imaging System Market

When an automated cell imaging system is destroyed, its spare parts must be completely replaced, which comes at a very high cost. It's because there is a supply side shortfall caused by the small number of manufacturers of this product. Additionally, the setup costs are relatively significant. Its operation also necessitates considerable electricity.

Market Trends of the Global Automated Cell Imaging System Market

Large pharmaceutical companies are heavily investing in new technology in an effort to develop new medications and vaccines. In long-term experiments, huge chemical libraries, or both, automated cell imaging methods reduce human error and the amount of time required for human intervention. High-resolution photos are collected and analyzed by the system.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Automated Cell Imaging System Market by Product

Market Overview
Time Lapse
and Colocalization
and Others

Global Automated Cell Imaging System Market by End users

Market Overview
Hospitals
Research and Diagnostic Laboratories.

Global Automated Cell Imaging System Market by Application

Market Overview
Live Cell Vivo Imaging
and Screening.

Global Automated Cell Imaging System Market by Technology

Market Overview
Fluorescence
Luminescence
Phase Contrast
and Others

Global Automated Cell Imaging System Market by Region

Market Overview
Asia Pacific
Europe
North America
Middle East & Africa
and Latin America

Global Automated Cell Imaging System Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Carl Zeiss AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Leica Microsystems GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nikon Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Molecular Devices LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD Biosciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioTek Instruments, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tecan Group AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Yokogawa Electric Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hamilton Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments